Bio News
Nature sister journal publishes explainable AI framework ‘CAML’ Visualizes decision-making while maintaining diagnostic accuracy

A new framework, CAML, that explains the basis for medical artificial intelligence (AI) decisions has been developed and published in a Nature sister journal (IF 26.7). The technology visualizes the AI’s decision-making process by separating decisive patterns from individual background factors while maintaining nearly perfect diagnostic accuracy. It is expected to help extract medical knowledge not identified during training and support the discovery of clinical rules and knowledge using AI technology.

BIOBOOK TEAM
biobookmedia@biobook.co.krAribio’s AR1001 Meets Primary Endpoint in Phase 3 Alzheimer’s Trial
GC녹십자 Signs MOU With Dongbang FTL to Collaborate on LNP Production
CG Oncology: Cretostimogene Cuts Bladder Cancer Recurrence Risk by 68%; FDA Filing to Expand
CG Oncology: 68% Lower Risk of Bladder Cancer Recurrence; Shares Surge 12%
U.S. FDA Rejects Summit and Akeso’s PD-1/VEGF Lung Cancer Drug
Biogen Signs $411 Million Deal With Trimtech for Neurodegenerative Diseases